About DATROWAY

Designed to identify and destroy cancer cells

DATROWAY was designed to deliver medicine directly to cancer cells. Discover what makes up DATROWAY and how it is thought to work.

What is DATROWAY?

DATROWAY is a type of treatment known as an antibody-drug conjugate, or an ADC for short. Let’s break down what that means.

Image of the DATROWAY® molecule
  • ANTIBODY 

    This is a protein designed to resemble your body's natural antibodies, which the immune system produces to combat infections and harmful substances. The antibody targets and attaches to a specific protein found on cancer cells. In the case of DATROWAY, it attaches to the protein Trop-2.

  • DRUG

    This is the chemical that the antibody releases to attack and destroy the cancer cells.

  • CONJUGATE

    This is a scientific way of saying “combination”. DATROWAY is an antibody combined with the medicine that destroys cancer cells.

How DATROWAY is thought to work

DATROWAY is designed to release medicine at the right place, inside the cancer cell

DATROWAY is designed to identify cancer cells that have Trop-2 (pronounced: trohp-too), a protein found on the surface of your cancer cells.

DATROWAY is designed to work in three steps

DATROWAY works by finding cancer cells that have Trop-2 so that it can attack and destroy them. Although DATROWAY is designed to target Trop-2 on cancer cells, it may affect some healthy cells. DATROWAY may not work for everyone.

Information from laboratory studies suggests that this is how DATROWAY works. The clinical relevance of these features is under investigation.

Trop-2=trophoblast cell-surface antigen 2.

Learn how to access and afford treatment